Track Omega Therapeutics's current assets ($39M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2024), OMGA shows a current assets of $39M. That compares with $100M in the prior-year period — down 61.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, OMGA's current assets is now $39M (was $100M) — a 61.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Omega Therapeutics is outperforming or lagging.
Tracking OMGA's current assets over time shows whether Omega Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $39M That compares with $100M in the prior-year period — down 61.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Omega Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $39M) with ownership activity and broader fundamentals.
Omega Therapeutics's current assets is $39M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.